Clearstead Advisors’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.9K | Buy |
3,185
+1,694
| +114% | +$19.6K | ﹤0.01% | 1385 |
|
|
2025
Q1 | $13K | Buy |
1,491
+224
| +18% | +$1.96K | ﹤0.01% | 1539 |
|
|
2024
Q4 | $18.2K | Sell |
1,267
-125
| -9% | -$1.8K | ﹤0.01% | 1415 |
|
|
2024
Q3 | $31.4K | Buy |
1,392
+125
| +10% | +$2.82K | ﹤0.01% | 1302 |
|
|
2024
Q2 | $24.6K | Buy |
+1,267
| New | +$24.6K | ﹤0.01% | 1321 |
|
|
2022
Q2 | – | Sell |
-8
| Closed | -$1K | – | 1452 |
|
|
2022
Q1 | $1K | Hold |
8
| – | – | ﹤0.01% | 1328 |
|
|
2021
Q4 | $1K | Hold |
8
| – | – | ﹤0.01% | 1219 |
|
|
2021
Q3 | $1K | Hold |
8
| – | – | ﹤0.01% | 1246 |
|
|
2021
Q2 | $2K | Hold |
8
| – | – | ﹤0.01% | 1087 |
|
|
2021
Q1 | $1K | Hold |
8
| – | – | ﹤0.01% | 1078 |
|
|
2020
Q4 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 959 |
|